Time on treatment with abiraterone in men with de novo metastatic castration sensitive prostate cancer: a drug utilization study. (4th March 2022)

Record Type:: Journal Article
Title:: Time on treatment with abiraterone in men with de novo metastatic castration sensitive prostate cancer: a drug utilization study. (4th March 2022)
Main Title:: Time on treatment with abiraterone in men with de novo metastatic castration sensitive prostate cancer: a drug utilization study
Authors:: Gedeborg, Rolf
Garmo, Hans
Thellenberg-Karlsson, Camilla
Fallara, Giuseppe
Styrke, Johan
Franck Lissbrant, Ingela
Stattin, Pär
Abstract:
Is Part Of:: Acta oncologica. Volume 61:Number 3(2022)
Journal:: Acta oncologica
Issue:: Volume 61:Number 3(2022)
Issue Display:: Volume 61, Issue 3 (2022)
Year:: 2022
Volume:: 61
Issue:: 3
Issue Sort Value:: 2022-0061-0003-0000
Page Start:: 328
Page End:: 332
Publication Date:: 2022-03-04
Subjects:: Oncology -- Periodicals
Cancer -- Treatment -- Periodicals
616.992
Journal URLs:: http://informahealthcare.com/loi/onc ↗
http://informahealthcare.com ↗
DOI:: 10.1080/0284186X.2021.2023215 ↗
Languages:: English
ISSNs:: 0284-186X
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 0641.705000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 21124.xml